| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |